• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
MacroGenics, Inc. - Strategic SWOT Analysis Review - Product Image

MacroGenics, Inc. - Strategic SWOT Analysis Review

  • Published: January 2013
  • 25 pages
  • GlobalData

FEATURED COMPANIES

  • Aphios Corporation
  • Aphton Corporation
  • Arteriocyte, Inc.
  • MORE

Summary

MacroGenics, Inc. (MacroGenics) is a privately held and venture capital backed biotechnology company with focus on the discovery, development and delivery of novel biologics for infectious diseases, cancer and autoimmune disorders. MacroGenics proprietary research is based on three core proprietary technology platforms which include Cancer Stem Cell Platform, Dual-Affinity Re-Targeting (or DART) Platform and Fc optimization Platform. The lead autoimmune product candidate of the company, teplizumab, is currently undergoing development for the prevention and treatment of early onset of type 1 diabetes.

Our MacroGenics, Inc. provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
MacroGenics, Inc. - Key Facts
MacroGenics, Inc. - Key Employees
MacroGenics, Inc. - Key Employee Biographies
MacroGenics, Inc. - Major Products and Services
MacroGenics, Inc. - Pharmaceutical Pipeline Products Data
MacroGenics, Inc., Pipeline Products by Therapy Area
MacroGenics, Inc., Pipeline Products by Development Phase
MacroGenics, Inc. - History
MacroGenics, Inc. - Company Statement
MacroGenics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
MacroGenics, Inc. - Business Description
MacroGenics, Inc. - SWOT Analysis
SWOT Analysis - Overview
MacroGenics, Inc. - Strengths
Strength - Production Capabilities
Strength - Acquisition of Raven Biotechnologies
Strength - Strong Technology Support
MacroGenics, Inc. - Weaknesses
Weakness - Lack of Marketed Products
MacroGenics, Inc. - Opportunities
Opportunity - Strategic Agreements
Opportunity - Robust Pipeline In Three Threpeutis Areas
Opportunity - Biotech Focus
Opportunity - Huge Market Potential: Cancer
MacroGenics, Inc. - Threats
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
MacroGenics, Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
MacroGenics, Inc., Recent Deals Summary
Section 4 – Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
MacroGenics, Inc., Key Facts
MacroGenics, Inc., Key Employees
MacroGenics, Inc., Key Employee Biographies
MacroGenics, Inc., Major Products and Services
MacroGenics, Inc., Number of Pipeline Products by Therapy Area
MacroGenics, Inc., Number of Pipeline Products by Development Stage
MacroGenics, Inc., Pipeline Products By Therapy Area and Development Phase
MacroGenics, Inc., History
MacroGenics, Inc., Other Locations
MacroGenics, Inc., Subsidiaries
MacroGenics, Inc., Key Competitors
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
MacroGenics, Inc., Recent Deals Summary

List of Figures
MacroGenics, Inc., Pipeline Products by Therapy Area
MacroGenics, Inc., Pipeline Products by Development Phase
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
MacroGenics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

BioCryst Pharmaceuticals, Inc.
Aphton Corporation
Aphios Corporation
Arteriocyte, Inc.
Advanced Life Sciences holdings, Inc.

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS